158 related articles for article (PubMed ID: 34410580)
1. Abnormal expression of NF-κB-related transcripts in blood of patients with inflammatory peripheral nerve disorders.
Azimi T; Ghafouri-Fard S; Badrlou E; Omrani MD; Nazer N; Sayad A; Taheri M
Metab Brain Dis; 2021 Dec; 36(8):2369-2376. PubMed ID: 34410580
[TBL] [Abstract][Full Text] [Related]
2. Dysregulation of NF-κB-Associated LncRNAs in Autism Spectrum Disorder.
Honarmand Tamizkar K; Badrlou E; Aslani T; Brand S; Arsang-Jang S; Ghafouri-Fard S; Taheri M
Front Mol Neurosci; 2021; 14():747785. PubMed ID: 34658787
[TBL] [Abstract][Full Text] [Related]
3. Dysregulation of lncRNAs in autoimmune neuropathies.
Gholipour M; Taheri M; Mehvari Habibabadi J; Nazer N; Sayad A; Ghafouri-Fard S
Sci Rep; 2021 Aug; 11(1):16061. PubMed ID: 34373511
[TBL] [Abstract][Full Text] [Related]
4. DICER-AS1 lncRNA: A putative culprit in the pathogenesis of gastric cancer.
Afrough H; Ghafouri-Fard S; Yousefi H; Pakzad P; Kholghi Oskooei V; Taheri M
Exp Mol Pathol; 2020 Oct; 116():104490. PubMed ID: 32663487
[TBL] [Abstract][Full Text] [Related]
5. Expression analysis of NF-κB interacting long noncoding RNAs in breast cancer.
Dashti S; Ghafouri-Fard S; Esfandi F; Oskooei VK; Arsang-Jang S; Taheri M
Exp Mol Pathol; 2020 Feb; 112():104359. PubMed ID: 31837323
[TBL] [Abstract][Full Text] [Related]
6. Expression Analysis of NF-κB-Related lncRNAs in Parkinson's Disease.
Ghafouri-Fard S; Gholipour M; Abak A; Mazdeh M; Taheri M; Sayad A
Front Immunol; 2021; 12():755246. PubMed ID: 34721431
[TBL] [Abstract][Full Text] [Related]
7. Expression of NF-κB associated lncRNAs in schizophrenia.
Safa A; Badrlou E; Arsang-Jang S; Sayad A; Taheri M; Ghafouri-Fard S
Sci Rep; 2020 Oct; 10(1):18105. PubMed ID: 33093650
[TBL] [Abstract][Full Text] [Related]
8. Expression analysis of BDNF, BACE1 and their antisense transcripts in inflammatory demyelinating polyradiculoneuropathy.
Ghafouri-Fard S; Mazdeh M; Nicknafs F; Nazer N; Sayad A; Taheri M
Mult Scler Relat Disord; 2021 Jan; 47():102613. PubMed ID: 33160139
[TBL] [Abstract][Full Text] [Related]
9. Expression of NF-κB-associated lncRNAs in different types of migraine.
Akbari M; Gholipour M; Davoudikianersi H; Hussen BM; Abak A; Eslami S; Ghafouri-Fard S; Sayad A
Acta Neurol Belg; 2023 Oct; 123(5):1823-1831. PubMed ID: 36066813
[TBL] [Abstract][Full Text] [Related]
10. Differentiation Between Guillain-Barré Syndrome and Acute-Onset Chronic Inflammatory Demyelinating Polyradiculoneuritis-a Prospective Follow-up Study Using Ultrasound and Neurophysiological Measurements.
Grimm A; Oertl H; Auffenberg E; Schubert V; Ruschil C; Axer H; Winter N
Neurotherapeutics; 2019 Jul; 16(3):838-847. PubMed ID: 30756363
[TBL] [Abstract][Full Text] [Related]
11. Over-Expression of Immune-Related lncRNAs in Inflammatory Demyelinating Polyradiculoneuropathies.
Sadeghpour S; Ghafouri-Fard S; Mazdeh M; Nicknafs F; Nazer N; Sayad A; Taheri M
J Mol Neurosci; 2021 May; 71(5):991-998. PubMed ID: 33057965
[TBL] [Abstract][Full Text] [Related]
12. Interleukin 8, a Biomarker to Differentiate Guillain-Barré Syndrome From CIDP.
Breville G; Lascano AM; Roux-Lombard P; Vuilleumier N; Lalive PH
Neurol Neuroimmunol Neuroinflamm; 2021 Jul; 8(5):. PubMed ID: 34140310
[TBL] [Abstract][Full Text] [Related]
13. Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective study.
Ruts L; Drenthen J; Jacobs BC; van Doorn PA;
Neurology; 2010 May; 74(21):1680-6. PubMed ID: 20427754
[TBL] [Abstract][Full Text] [Related]
14. Validation of elevated levels of interleukin-8 in the cerebrospinal fluid, and discovery of new biomarkers in patients with GBS and CIDP using a proximity extension assay.
Kmezic I; Gustafsson R; Fink K; Svenningsson A; Samuelsson K; Ingre C; Olsson T; Hansson M; Kockum I; Adzemovic MZ; Press R
Front Immunol; 2023; 14():1241199. PubMed ID: 38077366
[TBL] [Abstract][Full Text] [Related]
15. T cell reactivity to P0, P2, PMP-22, and myelin basic protein in patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
Csurhes PA; Sullivan AA; Green K; Pender MP; McCombe PA
J Neurol Neurosurg Psychiatry; 2005 Oct; 76(10):1431-9. PubMed ID: 16170091
[TBL] [Abstract][Full Text] [Related]
16. Genetics of Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): current knowledge and future directions.
Blum S; McCombe PA
J Peripher Nerv Syst; 2014 Jun; 19(2):88-103. PubMed ID: 25039604
[TBL] [Abstract][Full Text] [Related]
17. Expression Analysis of Protein Inhibitor of Activated STAT in Inflammatory Demyelinating Polyradiculoneuropathy.
Ghafouri-Fard S; Hussen BM; Nicknafs F; Nazer N; Sayad A; Taheri M
Front Immunol; 2021; 12():659038. PubMed ID: 34054823
[TBL] [Abstract][Full Text] [Related]
18. Dysregulation of NF-κB-Associated lncRNAs in Multiple Sclerosis Patients.
Safa A; Arsang-Jang S; Taheri M; Omrani MD; Ghafouri-Fard S
J Mol Neurosci; 2021 Jan; 71(1):80-88. PubMed ID: 32613554
[TBL] [Abstract][Full Text] [Related]
19. Nerve Ultrasound Score in Chronic Inflammatory Demyelinating Polyneuropathy.
Tan CY; Yahya MA; Goh KJ; Shahrizaila N
Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109705
[No Abstract] [Full Text] [Related]
20. CSF sphingomyelin: a new biomarker of demyelination in the diagnosis and management of CIDP and GBS.
Capodivento G; De Michelis C; Carpo M; Fancellu R; Schirinzi E; Severi D; Visigalli D; Franciotta D; Manganelli F; Siciliano G; Beronio A; Capello E; Lanteri P; Nobile-Orazio E; Schenone A; Benedetti L; Nobbio L
J Neurol Neurosurg Psychiatry; 2021 Mar; 92(3):303-310. PubMed ID: 33093191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
